Comparing RIT Capital Partners & Glaxosmithkline

This page explains how RIT Capital Partners compares with Glaxosmithkline

In terms of market cap, RIT Capital Partners is 25.25 times lesser than Glaxosmithkline, and each share in RIT Capital Partners is the equivalent to 1.16 shares in Glaxosmithkline.

  RCP   GSK
Price 2,210.00+309.001,901.00
Change 15.00 (0.68%)+2.11-27.50 (-1.43%)
Spread 10.00 (0.455%)+0.4021.00 (0.053%)
Currency GBX GBX
Sector Closed End Investments Medicine and Biotech
Indices UK All-Share, UK 250, UK 350  UK All-Share, UK 350 , UK 100
RIT Capital Partners Intraday Chart
Glaxosmithkline Intraday Chart
RIT Capital Partners 3 Month Chart
Glaxosmithkline 3 Month Chart
What if I invested £1,000?
1 month ago 1 year ago
RCP.LN/A N/A N/A N/A N/A
GSK.LN/A N/A N/A N/A N/A
  RCP   GSK
Shares in Issue 136,011,431   3,991,945,533
Market Capitalisation £3,005,852,625   £75,886,884,582
52 Week High 2,280.00   2,282.00
52 Week Low 1,844.00   1,315.00